We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency.
- Authors
Franco, E.; Shaw‐Smith, C.; Flanagan, S. E.; Edghill, E. L.; Wolf, J.; Otte, V.; Ebinger, F.; Varthakavi, P.; Vasanthi, T.; Edvardsson, S.; Hattersley, A. T.; Ellard, S.
- Abstract
Aims Recessive PDX1 ( IPF1) mutations are a rare cause of pancreatic agenesis, with three cases reported worldwide. A recent report described two cousins with a homozygous hypomorphic PDX1 mutation causing permanent neonatal diabetes with subclinical exocrine insufficiency. The aim of our study was to investigate the possibility of hypomorphic PDX1 mutations in a large cohort of patients with permanent neonatal diabetes and no reported pancreatic hypoplasia or exocrine insufficiency. Methods PDX1 was sequenced in 103 probands with isolated permanent neonatal diabetes in whom ABCC8, KCNJ11 and INS mutations had been excluded. Results Sequencing analysis identified biallelic PDX1 mutations in three of the 103 probands with permanent neonatal diabetes (2.9%). One proband and his affected brother were compound heterozygotes for a frameshift and a novel missense mutation (p.A34fsX191; c.98dupC and p.P87L; c.260C>T). The other two probands were homozygous for novel PDX1 missense mutations (p.A152G; c.455C>G and p.R176Q; c.527G>A). Both mutations affect highly conserved residues located within the homeobox domain. None of the four cases showed any evidence of exocrine pancreatic insufficiency, either clinically, or, where data were available, biochemically. In addition a heterozygous nonsense mutation (p.C18X; c.54C>A) was identified in a fourth case. Conclusions This study demonstrates that recessive PDX1 mutations are a rare but important cause of isolated permanent neonatal diabetes in patients without pancreatic hypoplasia/agenesis. Inclusion of the PDX1 gene in mutation screening for permanent neonatal diabetes is recommended as a genetic diagnosis reveals the mode of inheritance, allows accurate estimation of recurrence risks and confirms the requirement for insulin treatment.
- Subjects
GENETICS of diabetes; PANCREATIC physiology; GENETIC testing; PANCREAS; EXOCRINE pancreatic insufficiency; DIABETES; PEOPLE with diabetes; GENETICS; INSULIN; MOLECULAR biology; GENETIC mutation; PEDIATRICS; DIAGNOSIS; ANATOMY
- Publication
Diabetic Medicine, 2013, Vol 30, Issue 5, pe197
- ISSN
0742-3071
- Publication type
Article
- DOI
10.1111/dme.12122